Metastatic
S2107
Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable Colorectal Cancer
WF-1806
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
